Jarislowsky, Fraser Ltd’s Johnson & Johnson Position
Does Jarislowsky, Fraser Ltd own Johnson & Johnson (JNJ)? Yes — 450.5K shares worth $84M (+0.46% of its 13F portfolio) as of Q3 2025, down from 472.8K shares the prior filed quarter.
Position Value
$84M
Q3 2025
Shares
450.5K
% of Portfolio
+0.46%
Quarters Held
28
currently held
Position History JNJ
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2025 | 450.5K | $84M | +0.46% |
| Q2 2025 | 472.8K | $72M | +0.41% |
| Q1 2025 | 478.6K | $79M | +0.50% |
| Q4 2024 | 488.6K | $71M | +0.41% |
| Q3 2024 | 512.0K | $83M | +0.46% |
| Q2 2024 | 535.6K | $78M | +0.48% |
| Q1 2024 | 654.9K | $103,600 | +0.59% |
| Q4 2023 | 682.0K | $106,900 | +0.63% |
| Q3 2023 | 688.9K | $107,299 | +0.70% |
| Q2 2023 | 699.4K | $115,759 | +0.69% |
| Q1 2023 | 706.6K | $109,524 | +0.68% |
| Q4 2022 | 724.5K | $127,978 | +0.84% |
| Q3 2022 | 740.1K | $121M | +0.84% |
| Q2 2022 | 753.8K | $134M | +0.85% |
| Q1 2022 | 778.4K | $138M | +0.74% |
| Q4 2021 | 807.6K | $138M | +0.64% |
| Q3 2021 | 844.9K | $136M | +0.66% |
| Q2 2021 | 878.9K | $145M | +0.68% |
| Q1 2021 | 914.0K | $150M | +0.74% |
| Q4 2020 | 947.5K | $149M | +0.76% |
| Q3 2020 | 979.6K | $146M | +0.86% |
| Q2 2020 | 1.37M | $192M | +1.20% |
| Q1 2020 | 1.31M | $171M | +1.25% |
| Q4 2019 | 1.30M | $190M | +1.01% |
| Q3 2019 | 1.31M | $170M | +0.96% |
| Q2 2019 | 1.32M | $184M | +1.12% |
| Q1 2019 | 1.35M | $189M | +1.18% |
| Q4 2018 | 1.45M | $187M | +1.28% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Jarislowsky, Fraser Ltd’s full portfolio or all institutional holders of JNJ.